Electrostatic interaction of internal Mg2+ with membrane PIP2 Seen with KCNQ K+ channels

J Gen Physiol. 2007 Sep;130(3):241-56. doi: 10.1085/jgp.200709821.

Abstract

Activity of KCNQ (Kv7) channels requires binding of phosphatidylinositol 4,5-bisphosphate (PIP(2)) from the plasma membrane. We give evidence that Mg(2+) and polyamines weaken the KCNQ channel-phospholipid interaction. Lowering internal Mg(2+) augmented inward and outward KCNQ currents symmetrically, and raising Mg(2+) reduced currents symmetrically. Polyvalent organic cations added to the pipette solution had similar effects. Their potency sequence followed the number of positive charges: putrescine (+2) < spermidine (+3) < spermine (+4) < neomycin (+6) < polylysine (>>+6). The inhibitory effects of Mg(2+) were reversible with sequential whole-cell patching. Internal tetraethylammonium ion (TEA) gave classical voltage-dependent block of the pore with changes of the time course of K(+) currents. The effect of polyvalent cations was simpler, symmetric, and without changes of current time course. Overexpression of phosphatidylinositol 4-phosphate 5-kinase Igamma to accelerate synthesis of PIP(2) attenuated the sensitivity to polyvalent cations. We suggest that Mg(2+) and other polycations reduce the currents by electrostatic binding to the negative charges of PIP(2), competitively reducing the amount of free PIP(2) available for interaction with channels. The dose-response curves could be modeled by a competition model that reduces the pool of free PIP(2). This mechanism is likely to modulate many other PIP(2)-dependent ion channels and cellular processes.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Binding, Competitive
  • Cell Line
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Dose-Response Relationship, Drug
  • Humans
  • Ion Channel Gating* / drug effects
  • KCNQ2 Potassium Channel / drug effects
  • KCNQ2 Potassium Channel / genetics
  • KCNQ2 Potassium Channel / metabolism*
  • KCNQ3 Potassium Channel / drug effects
  • KCNQ3 Potassium Channel / genetics
  • KCNQ3 Potassium Channel / metabolism*
  • Magnesium / metabolism*
  • Membrane Potentials
  • Mice
  • Minor Histocompatibility Antigens
  • Models, Biological
  • Neomycin / metabolism
  • Phosphatidylinositol 4,5-Diphosphate / metabolism*
  • Phosphotransferases (Alcohol Group Acceptor) / genetics
  • Phosphotransferases (Alcohol Group Acceptor) / metabolism
  • Polyamines / metabolism*
  • Polyamines / pharmacology
  • Polylysine / metabolism
  • Potassium / metabolism*
  • Potassium Channel Blockers / pharmacology
  • Putrescine / metabolism
  • Rats
  • Spermidine / metabolism
  • Spermine / metabolism
  • Static Electricity
  • Tetraethylammonium / pharmacology
  • Time Factors
  • Transfection

Substances

  • KCNQ2 Potassium Channel
  • KCNQ2 protein, human
  • KCNQ3 Potassium Channel
  • Kcnq3 protein, rat
  • Minor Histocompatibility Antigens
  • Phosphatidylinositol 4,5-Diphosphate
  • Polyamines
  • Potassium Channel Blockers
  • Polylysine
  • Spermine
  • Tetraethylammonium
  • Phosphotransferases (Alcohol Group Acceptor)
  • phosphatidylinositol phosphate 4-kinase
  • Neomycin
  • Magnesium
  • Potassium
  • Spermidine
  • Putrescine